90
Participants
Start Date
June 30, 1995
Primary Completion Date
August 31, 2002
aldesleukin
recombinant interferon alfa
cisplatin
dacarbazine
Institut Jules Bordet, Brussels (Bruxelles)
Hopital Universitaire Erasme, Brussels
Instituto Portugues de Oncologia do Porto, Porto
Istituto Europeo Di Oncologia, Milan
CHR de Besancon - Hopital Saint-Jacques, Besançon
Centre Leon Berard, Lyon
CHU Pitie-Salpetriere, Paris
Landeskrankenanstalten - Salzburg, Salzburg
Universitair Ziekenhuis Antwerpen, Edegem
U.Z. Gasthuisberg, Leuven
Universitaetsklinikum Charite, Berlin
Universitaetsklinikum Benjamin Franklin, Berlin
Robert Roessle Klinik, Berlin
Haematologisch-Onkologische Praxis Altona, Hamburg
Johannes Gutenberg University, Mainz
III Medizinische Klinik Mannheim, Mannheim
University Medical Center Nijmegen, Nijmegen
Rotterdam Cancer Institute, Rotterdam
Centre Hospitalier Universitaire Vaudois, Lausanne
Universitaetsspital, Zurich
St. James's Hospital, Leeds
Royal Marsden NHS Trust, London
Southend NHS Trust Hospital, Westcliff-on-Sea
Royal Bournemouth Hospital, Bournemouth
European Organisation for Research and Treatment of Cancer - EORTC
NETWORK